Xxera/openscience/retractions

Record #7255

Silencing EGFR/HER3 signaling with a novel anti-EGFR domain II/IV antibody

Shi Hu, Haibin Dai, Tiancheng Zhang, Wenyan Fu, Sandra D Berezov, Cheng Chen, Daniel Jorissen, Hiroaki Takeda, Augus N Bethune

Journal

Publisher

Original paper date

Nov 27, 2014

Original DOI

10.1016/j.canlet.2014.11.053

Country

Institution

Translational Medicine Research Institute, International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433, China · Cancer Center, PLA General Hospital, PLA Postgraduate School of Medicine, 28 Fuxing Road, Beijing 100853, China · Asian-Pacific Biosignatures Center, Tianjin Joint Academy of Biomedicine and Technology, Tianjin 300457, China · Department of Anesthesiology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China · School of Life Sciences, Tianjin University, Tianjin 300072, China · Molecular Drug Discovery Center, Xi'an Jinwa Pharmaceutical Co., Ltd, Xi'an, Shaanxi 710000, China

Open access

No

Article type

Research Article

Broad categories

(BLS) Biology - Cancer (BLS) Biology - Cellular (BLS) Genetics (HSC) Medicine - Drug Design (HSC) Medicine - Oncology

Citation lifecycle

How this paper is being cited

Pre-retraction

1

Same day

0

Post-retraction

2

% post-retraction

66.7%

~0.4 citations/yr before retraction · ~0.2 citations/yr after

— citing papers

Who is still citing this work

Loading…